Pharmaceutical Technology

OCTOBER 28, 2022

They inform industrial scientists what is necessary to ensure that their product meets the safety and efficacy requirements to get a product approved in humans. For companies in the US, if the results show bioequivalence, an abbreviated new drug application (ANDA) containing the results is sent to the FDA to review and potentially approve.

Bioequivalency 130

Bioequivalency Production Contamination Branding 130

XTalks

AUGUST 2, 2023

2) Veklury (remdesivir) Veklury, approved by the FDA in 2020, is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor designed for the treatment of COVID-19. Veklury generated a revenue of $3.91 Moderna, a pharma and biotech company based in Massachusetts, specializes in RNA therapeutics, particularly mRNA vaccines.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

SEPTEMBER 14, 2020

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. Chinese scientists also announced last week that they have isolated several antibodies that block the ability of COVID-19 from entering cells and replicating, thus potentially preventing the infection from occurring.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92